CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
CDK4/6-Cyclin D pathway is often deregulated in cancer; therefore specific inhibitors have been developed. Here the authors show that treatment with CDK4/6 inhibitors activate autophagy in breast cancer cells; thus, combination of such inhibitors with autophagy inhibitors results in a synergistic ef...
Enregistré dans:
Auteurs principaux: | Smruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, Xian Chen, Tuyen Bui, Min Yi, Akshara S. Raghavendra, Yang Zhao, Sami I. Bashour, Nuhad K. Ibrahim, Meghan Karuturi, Jing Wang, Jeffrey D. Winkler, Ravi K. Amaravadi, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/29244e97db3b4325b02bb495622f99c7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
par: Ang Gao, et autres
Publié: (2018) -
Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability
par: Rafaela Fagundes, et autres
Publié: (2021) -
Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
par: Grzegorz Sarek, et autres
Publié: (2010) -
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
par: Lindsey R. Pack, et autres
Publié: (2021) -
AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy
par: Marc Dohmen, et autres
Publié: (2020)